Skip to main content
SpringerLink
Log in

Active Surveillance for Favorable Risk Prostate Cancer: Background, Patient Selection, Triggers for Intervention, and Outcomes

  • Chapter
  • First Online:
Management of Prostate Cancer

  • 970 Accesses

Abstract

Modern medicine, with its emphasis on early detection of disease, has enhanced the health of men and women throughout the world. However, early detection of disease carries with it a significant risk of overdetection of conditions that, although they fulfill pathological or clinical criteria for disease, pose little or no threat to the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bill-Axelson A, Holmberg L et al (2011) RP vs WW in early PCa. N Engl J Med 364:18

    Article  Google Scholar 

  • Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A (2010) Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 46(17):3040–3052

    Article  PubMed  CAS  Google Scholar 

  • Carter HB, Kettermann A, Warlick C, Metter EJ, Landis P, Walsh PC, Epstein JI (2007) Expectant management of prostate cancer with curative intent: an update of the johns Hopkins experience. J Urol 178(6):2359–2365

    Article  PubMed  Google Scholar 

  • Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR (2011) Outcomes of active surveillance for men with intermediate risk prostate cancer. J Clin Oncol 29:228–234

    Article  PubMed  Google Scholar 

  • Davis JW, Kim J, Ward JF, Wang X, Nakanishi H, Babaian RJ, Troncoso P (2010) Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci. BJU Int 105:1386–1391

    Article  PubMed  Google Scholar 

  • Delongchamps NB, Beuvon F, Eiss D, Flam T, Muradyan N, Zerbib M, Peyromaure M, Cornud F (2011) Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer. Prostate Cancer Prostatic Dis 14:232–237

    Article  PubMed  CAS  Google Scholar 

  • Draisma G, Etzioni R, Tsodikov A et al (2009) Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 101:374–383

    Article  PubMed  Google Scholar 

  • Duffield AS, Lee TK, Miyamoto H, Carter HB, Epstein JI (2009) Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol 182(5):2274–2278

    Article  PubMed  Google Scholar 

  • Eggener S, Scardino P, Walsh P et al (2011) 20 year prostate cancer specific mortality after radical prostatectomy. J Urol 85(3):869–875

    Article  Google Scholar 

  • Fütterer JJ, Barentsz J, Heijmijnk ST (2009) Imaging modalities for prostate cancer. Expert Rev Anticancer Ther 9(7):923–937

    Article  PubMed  Google Scholar 

  • Greene KK, Albertsen PC, Babaian RJ et al (2009) PSA best practice statement: 2009 update. J Urol 182:2232–2241

    Article  PubMed  CAS  Google Scholar 

  • Hugosson J, Carlsson S, Aus G et al (2010) Mortality results from the Gotebörg randomised population-based prostate-cancer screening trial. Lancet Oncol 11:725–732

    Article  PubMed  Google Scholar 

  • Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO (1997) Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 277(6):467–471

    Article  PubMed  CAS  Google Scholar 

  • Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 141(5):1091–1094

    PubMed  CAS  Google Scholar 

  • Kane CJ, Im R, Amling CL, Presti JC Jr, Aronson WJ, Terris MK, Freedland SJ, SEARCH Database Study Group (2010) Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. Urology 76:695–700

    Article  PubMed  Google Scholar 

  • Khatami A, Hugusson PSA (2006) DT and surveillance. Int J Cancer 120:170–174

    Google Scholar 

  • Klotz L, Thompson I (2011) Early prostate cancer – treat or watch? N Engl J Med 365(6):569

    Article  PubMed  CAS  Google Scholar 

  • Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A (2010) Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28(1):126–131

    Article  PubMed  Google Scholar 

  • Loblaw A, Zhang L, Lam A, Nam R, Mamedov A, Vesprini D, Klotz L (2010) Comparing prostate specific antigen triggers for intervention in men with stable prostate cancer on active surveillance. J Urol 184(5):1942–1946

    Article  PubMed  Google Scholar 

  • Mufarrij P, Sankin A, Godoy G, Lepor H (2010) Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy. Urology 76:689–692

    Article  PubMed  Google Scholar 

  • Oliveira IS, Pontes-Junior J, Abe DK, Crippa A, Dall’oglio MF, Nesralah AJ, Leite KR, Reis ST, Srougi M (2010) Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy. Int Braz J Urol 36(3):292–299

    PubMed  Google Scholar 

  • Ploussard G, Salomon L, Xylinas E, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A (2010) Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance–does the risk of misclassification vary according to biopsy criteria? J Urol 183(2):539–544

    Article  PubMed  Google Scholar 

  • Raventós CX, Orsola A, de Torres I, Cecchini L, Trilla E, Planas J, Morote J (2010) Preoperative prediction of pathologically insignificant prostate cancer in radical prostatectomy specimens: the role of prostate volume and the number of positive cores. Urol Int 84(2):153–158

    Article  PubMed  Google Scholar 

  • Roemeling S, Roobol MJ, de Vries SH, Wolters T, Gosselaar C, van Leenders GJ, Schröder FH (2007) Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome. Eur Urol 51(5):1244–1250

    Article  PubMed  Google Scholar 

  • Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, Walsh PC (2010) Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program. J Clin Oncol 28(17):2810–2816

    Article  PubMed  CAS  Google Scholar 

  • Schroder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328

    Article  PubMed  Google Scholar 

  • Smaldone MC, Cowan JE, Carroll PR, Davies BJ (2010) Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort. J Urol 183(1):138–143

    Article  PubMed  Google Scholar 

  • Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M (2008) Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 101:165–169

    PubMed  Google Scholar 

  • Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ (2010) Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols. Urology 75(2):414–418

    Article  PubMed  Google Scholar 

  • Van As NJ, Parker C (2007) Active surveillance with selective radical treatment for localized prostate cancer. Cancer J 13(5):289–294

    Article  PubMed  Google Scholar 

  • van den Bergh RC, Roemeling S, Roobol MJ, Aus G, Hugosson J, Rannikko AS, Tammela TL, Bangma CH, Schröder FH (2009) Outcomes of men with screen-detected prostate cancer eligible for active surveillance Who were managed expectantly. Eur Urol 55(1):1–8

    Article  PubMed  Google Scholar 

  • van den Bergh RC, Steyerberg EW, Khatami A, Aus G, Pihl CG, Wolters T, van Leeuwen PJ, Roobol MJ, Schröder FH, Hugosson J (2010a) Swedish and Dutch sections of the European randomized study of screening for prostate cancer. Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116(5):1281–1290

    Article  PubMed  Google Scholar 

  • van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schröder FH, Bangma CH (2010b) Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int 105(7):956–962

    Article  PubMed  Google Scholar 

  • Vickers A (2008) Systematic review of pretreatment PSA velocity and doubling time as PCA predictors. J Clin Oncol 27:398–403

    Article  PubMed  Google Scholar 

  • Villeirs GM, De Meerleer GO, De Visschere PJ, Fonteyne VH, Verbaeys AC, Oosterlinck W (2011) Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. Eur J Radiol 77:340–345

    Article  PubMed  Google Scholar 

  • Welch HG, Black WC (2010) Overdiagnosis in cancer. J Natl Cancer Inst 102(9):605–613

    Article  PubMed  Google Scholar 

  • Wolters T, Roobol M, Schröder F, van der Kwast T (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data Set of a randomized screening trial. J Urol 185:121–125

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave.#MG408, Toronto, ON, M4N 3M5, Canada

    Laurence Klotz M.D.

Authors
  1. Laurence Klotz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurence Klotz M.D. .

Editor information

Editors and Affiliations

  1. , Department of Oncology and Radiotherapy, University Hospital, BP 217X, Grenoble, 38043, France

    Michel Bolla

  2. , Department of Urology, University Hospital, Herestraat 49, Leuven, 3000, Belgium

    Hendrik van Poppel

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Klotz, L. (2012). Active Surveillance for Favorable Risk Prostate Cancer: Background, Patient Selection, Triggers for Intervention, and Outcomes. In: Bolla, M., van Poppel, H. (eds) Management of Prostate Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27597-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27597-5_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-27596-8

  • Online ISBN: 978-3-642-27597-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation